Edition:
United Kingdom

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

47.76USD
19 Oct 2018
Change (% chg)

$-2.11 (-4.23%)
Prev Close
$49.87
Open
$49.87
Day's High
$50.94
Day's Low
$47.39
Volume
129,453
Avg. Vol
198,747
52-wk High
$96.51
52-wk Low
$41.06

Chart for

About

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a... (more)

Overall

Beta: --
Market Cap(Mil.): $3,132.52
Shares Outstanding(Mil.): 35.82
Dividend: --
Yield (%): --

Financials

  ONCE.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -6.38 -- --
ROI: -61.15 0.21 14.27
ROE: -63.88 1.17 15.99

BRIEF-Spark Therapeutics Reports Q1 Loss Per Share Of $1.25

* SPARK THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT BUSINESS PROGRESS

08 May 2018

BRIEF-Spark Therapeutics Says Entered Into Asset Purchase Agreement With Jazz Pharmaceuticals Ireland Ltd

* SPARK THERAPEUTICS SAYS ENTERED INTO ASSET PURCHASE AGREEMENT WITH JAZZ PHARMACEUTICALS IRELAND LIMITED - SEC FILING

30 Apr 2018

Earnings vs. Estimates